Insider · CIK 0001498376

Babiss Lee

Reports to the SEC for 2 companies · CLEVELAND, OH

sec.gov

Transactions

Companies

Filings

CIK

0001498376

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-06-18	ATHERSYS, INC / NEWNonQualified Stock Option (right to purchase)A Award	Director	AAward	+50K sh	—	—	50,000
2019-06-12	ATHERSYS, INC / NEWNonQualified Stock Option (right to purchase)A Award	Director	AAward	+50K sh	—	—	50,000
2018-06-18	ATHERSYS, INC / NEWNonQualified Stock Option (right to purchase)A Award	Director	AAward	+50K sh	—	—	50,000
2017-06-07	ATHERSYS, INC / NEWNonQualified Stock Option (right to purchase)A Award	Director	AAward	+30K sh	—	—	30,000
2016-06-20	ATHERSYS, INC / NEWNonQualified Stock Option (right to purchase)A Award	Director	AAward	+30K sh	—	—	30,000
2016-03-07	ATHERSYS, INC / NEWDirector Stock Option (right to purchase)A Award	Director	AAward	+75K sh	—	—	75,000
2015-06-24	ATHERSYS, INC / NEWDirector stock option (right to purchase)A Award	Director	AAward	+30K sh	—	—	30,000
2013-09-10	ATHERSYS, INC / NEWDirector stock option (right to purchase)A Award	Director	AAward	+15K sh	—	—	15,000
2013-06-18	ATHERSYS, INC / NEWDirector stock option (right to purchase)A Award	Director	AAward	+15K sh	—	—	15,000
2012-06-20	ATHERSYS, INC / NEWDirector stock option (right to purchase)A Award	Director	AAward	+15K sh	—	—	15,000
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Exec. VP--Global Lab Services	DDisposition to Issuer	−30K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Exec. VP--Global Lab Services	DDisposition to Issuer	−15K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Exec. VP--Global Lab Services	DDisposition to Issuer	−46.6K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCRestricted Stock UnitsD Disposition to Issuer	Exec. VP--Global Lab Services	DDisposition to Issuer	−10K sh	—	—	0
2011-06-16	ATHERSYS, INC / NEWDirector stock option (right to purchase)A Award	Director	AAward	+15K sh	—	—	15,000
2011-02-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCRestricted Stock UnitsA Award	Exec. VP--Global Lab Services	AAward	+10K sh	—	—	10,000
2011-02-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Exec. VP--Global Lab Services	AAward	+30K sh	—	—	30,000
2010-08-09	ATHERSYS, INC / NEWDirector stock option (right to purchase)A Award	Director	AAward	+75K sh	—	—	75,000

Recent filings

Accepted (ET)
Jun 184
Babiss Lee0001368148-20-000070
SEC(opens sec.gov)
Jun 144
Babiss Lee0001209191-19-037046
SEC(opens sec.gov)
Jun 194
Babiss Lee0001209191-18-038631
SEC(opens sec.gov)
Jun 94
ATHERSYS, INC / NEW0001209191-17-038706
SEC(opens sec.gov)
Jun 214
ATHERSYS, INC / NEW0001209191-16-129125
SEC(opens sec.gov)
Mar 94
ATHERSYS, INC / NEW0001209191-16-107262
SEC(opens sec.gov)
Jun 254
ATHERSYS, INC / NEW0001209191-15-056190
SEC(opens sec.gov)
Sep 114
ATHERSYS, INC / NEW0001209191-13-043820
SEC(opens sec.gov)
Jun 204
ATHERSYS, INC / NEW0001209191-13-033076
SEC(opens sec.gov)
Jun 224
Babiss Lee0001209191-12-035023
SEC(opens sec.gov)
Dec 64
Babiss Lee0001498376-11-000002
SEC(opens sec.gov)
Jun 204
Babiss Lee0001209191-11-035488
SEC(opens sec.gov)
Feb 254
Babiss Lee0001498376-11-000001
SEC(opens sec.gov)
Aug 104
Babiss Lee0001209191-10-041848
SEC(opens sec.gov)

Companies

Address

3201 CARNEGIE AVENUE

CLEVELAND, OH, 44115